TXA and Corona Virus 2019 (COVID19) in Outpatients
Status:
Terminated
Trial end date:
2021-04-21
Target enrollment:
Participant gender:
Summary
A controlled trial of the drug tranexamic acid (TXA) in outpatients who were recently
diagnosed with COVID-19. It is hypothesized that TXA will reduce the infectivity and
virulence of the virus.